Fulton Bank N.A. Has $314,000 Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

Fulton Bank N.A. cut its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 11.5% in the third quarter, HoldingsChannel reports. The fund owned 1,046 shares of the medical instruments supplier’s stock after selling 136 shares during the quarter. Fulton Bank N.A.’s holdings in West Pharmaceutical Services were worth $314,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of WST. Fidelis Capital Partners LLC acquired a new stake in West Pharmaceutical Services during the 1st quarter worth about $27,000. Crewe Advisors LLC boosted its position in West Pharmaceutical Services by 322.7% during the 2nd quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 71 shares during the period. Quarry LP lifted its holdings in shares of West Pharmaceutical Services by 155.3% during the 4th quarter. Quarry LP now owns 97 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 59 shares during the last quarter. Hazlett Burt & Watson Inc. acquired a new stake in shares of West Pharmaceutical Services during the 1st quarter valued at about $40,000. Finally, Northwest Investment Counselors LLC acquired a new stake in shares of West Pharmaceutical Services during the 1st quarter valued at about $40,000. 93.90% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, VP Charles Witherspoon sold 1,029 shares of the business’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total value of $308,700.00. Following the completion of the sale, the vice president now directly owns 1,478 shares in the company, valued at approximately $443,400. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.53% of the stock is owned by corporate insiders.

West Pharmaceutical Services Stock Up 0.0 %

Shares of West Pharmaceutical Services stock opened at $286.52 on Thursday. The firm has a market cap of $20.78 billion, a price-to-earnings ratio of 37.80, a P/E/G ratio of 10.57 and a beta of 1.01. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.34 and a quick ratio of 1.68. West Pharmaceutical Services, Inc. has a 52-week low of $265.00 and a 52-week high of $413.70. The stock has a 50-day simple moving average of $300.79 and a 200-day simple moving average of $329.87.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.22). The firm had revenue of $702.10 million for the quarter, compared to analyst estimates of $729.36 million. West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The firm’s quarterly revenue was down 6.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.11 earnings per share. On average, equities research analysts expect that West Pharmaceutical Services, Inc. will post 6.42 earnings per share for the current fiscal year.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.